The in vitro activity of HR756, a new semisynthetic cephalosporin, was compared with the activities of cephalothin, cefoxitin, and cefamandole against 1,535 isolates of gram-positive and gram-negative bacteria. HR756 was less active than cephalothin and cefamandole and twofold more active than cefoxitin against Staphylococcus. All four of the antibiotics were inactive against the enterococcus group of Streptococcus; however, HR756 was the most active antibiotic against the other isolates of Streptococcus. HR756 was also more active against isolates of Enterobacteriaceae, including 84 to 95% of the isolates resistant to one or more of the other three antibiotics. HR756, at a concentration of 12.5 ,ug/ml, inhibited 86, 75, and 100% of the isolates of Pseudomonas aeruginosa, other Pseudomonas species, and Acinetobacter, respectively. The minimal inhibitory concentrations and minimal bactericidal concentrations of HR756 were within one twofold dilution for 11 of 21 gram-positive cocci and 119 of 125 gram-negative bacilli tested.
Cephalosporins are broad-spectrum antibiotics with activity against most gram-positive and gram-negative bacteria. Unfortunately the emergence of multiply antibiotic-resistant bacteria, particularly among the gram-negative bacillus class, has become a serious therapeutic problem and has stimulated the search for newer antibiotics (2, 5) . One such agent is HR756, a new semisynthetic cephalosporin which is resistant to all of the five classes of f8-lactamases defined by Richmond (3; K. P. Fu and H. C. Neu, Abstr. Annu. Meet. Am. Soc. Microbiol. 1978, A10, p. 2). In this study the in vitro activity of HR756 was tested against 1,535 isolates of bacteria and compared with the activities of cephalothin, cefamandole, and the cephamycin antibiotic cefoxitin. (Table 3 ). The MBC-MIC ratio for HR756 was 1 or 2 for 11 of the 21 gram-positive cocci and 119 of the 125 gram-negative bacilli. Greater than a one dilution difference (ratio greater than two) between MIC and MBC was noted for S. aureus (7 of 14 isolates), enterococci (all 3 isolates), Pseudomonas (3 of 20 isolates), Enterobacter (1 of 8 isolates), and Proteus (2 of 19 isolates). In the study reported herein HR756 was active against isolates of Staphylococcus, nonenterococcal Streptococcus, Enterobacteriaceae, and Acinetobacter. A most interesting finding was its apparent activity against P. aeruginosa and other Pseudomonas species.
MATERLALS AND METHODS
In comparison with the other antibiotics which were tested, HR756 was less active than cephalothin and cefamandole against Staphylococcus; however, 97 to 99% of the isolates were inhibited by 6.2 ,ug of HR756 per ml. HR756 was approximately twofold more active than cefoxitin against staphylococci. MBCs of HR756 for 6 of 14 isolates of S. aureus were more than fourfold greater than the MICs. This is similar to the proportion of clinical isolates of S. aureus which are tolerant to the bactericidal activity of cephalothin (1, 4) .
HR756 was very active against isolates of Enterobacteriaceae which were both susceptible and resistant to the other antibiotics tested. This was particularly true with isolates of Enterobacter, Citrobacter, indole-positive Proteus, and Serratia, against which the other antibiotics were much less active. In addition, the MBC-MIC ratio of HR756 was 1 or 2 for all isolates of Enterobacteriaceae except one Enterobacter and two Proteus.
The activity of HR756 against Pseudomonas, particularly P. aeruginosa, and Acinetobacter was especially noteworthy, in that 77 to 100% of the isolates were inhibited by c12.5 ,ug/ml and the antibiotic was bactericidal for all but three isolates.
We have assumed that blood levels obtainable with HR756 are comparable to those achieved with the other cephalosporins. Preliminary data indicate that this is an accurate assumption (W. Novick, personal communication), but additional studies are needed to substantiate this. If the broad spectrum of activity is confirmed, this will be the first cephalosporin active against Pseudomonas and all genera of Enterobacteriaceae, as well as some gram-positive bacteria.
